FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Carmen Scheibenbogen

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Procedures

Physiology

Lymphocyte Activation

Concepts & Ideas

T-Lymphocyte Subsets

Co-author Network

Publications

TOP 3
Dusan Popadic; Ricardo Pujol-Borrell; Emina Savic; Carmen Scheibenbogen; Barbara Seliger; Sarah Thunberg; Maureen Turina; Federica Villanova; Ignacio Anegon; Dominique Baeten; Hermann Eibel; Thomas Giese; Per Marits; Eva Martinez-Caceres; Françoise Mascart; Frank Nestle; Ola Winqvist; Ann-Charlotte Wikström
Predictive immunomonitoring -- the COST ENTIRE initiative.
Sabrina Wilk; Chin-An Yang; Sandra Bauer; Katrin Göldner; Alexander Jenke; Katja Kotsch; Wolfgang Poller; Heinz-Peter Schultheiss; Carsten Skurk; Jenny Stehr; Hans-Dieter Volk; Carmen Scheibenbogen
Adiponectin modulates NK-cell function.
Robert Friedrich Kudernatsch; Anne Letsch; Harald Stachelscheid; Hans-Dieter Volk; Carmen Scheibenbogen
Doublets pretending to be CD34+ T cells despite doublet exclusion.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Carmen Scheibenbogen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Dusan Popadic; Ricardo Pujol-Borrell; Emina Savic; Carmen Scheibenbogen; Barbara Seliger; Sarah Thunberg; Maureen Turina; Federica Villanova; Ignacio Anegon; Dominique Baeten; Hermann Eibel; Thomas Giese; Per Marits; Eva Martinez-Caceres; Françoise Mascart; Frank Nestle; Ola Winqvist; Ann-Charlotte Wikström
Predictive immunomonitoring -- the COST ENTIRE initiative.
Clinical immunology (Orlando, Fla.) 2013;147(1):23-6.
2013: Sabrina Wilk; Chin-An Yang; Sandra Bauer; Katrin Göldner; Alexander Jenke; Katja Kotsch; Wolfgang Poller; Heinz-Peter Schultheiss; Carsten Skurk; Jenny Stehr; Hans-Dieter Volk; Carmen Scheibenbogen
Adiponectin modulates NK-cell function.
European journal of immunology 2013;43(4):1024-33.
2013: Robert Friedrich Kudernatsch; Anne Letsch; Harald Stachelscheid; Hans-Dieter Volk; Carmen Scheibenbogen
Doublets pretending to be CD34+ T cells despite doublet exclusion.
Cytometry. Part A : the journal of the International Society for Analytical Cytology 2013;83(2):173-6.
2013: Chin-An Yang; Sandra Bauer; Jan Bornschein; Stephan Hellmig; Christoph Kleinle; Peter Malfertheiner; Carmen Scheibenbogen; Ralf R Schumann; Thomas Wex; Lutz Hamann
A frequent Toll-like receptor 1 gene polymorphism affects NK- and T-cell IFN-γ production and is associated with Helicobacter pylori-induced gastric disease.
Helicobacter 2013;18(1):13-21.
2013: Il-Kang Na; Kathrin Rieger; Carmen Scheibenbogen; Igor Wolfgang Blau; Olga Blau; Mikalai Dziubianau; Anne Herholz; Désirée Kunkel; Angela Mensen; Eckhard Thiel; Lutz Uharek; Friedrich Wittenbecher; Andreas Thiel
Rabbit antithymocyte globulin (Thymoglobulin(R)) impairs the thymic output of both conventional and regulatory CD4+ T cells after allogeneic hematopoietic stem cell transplantation in adult patients.
Haematologica 2013;98(1):23-30.
2012: Peter Bobbert; Thomas Bobbert; Alexander Jenke; Uwe Kühl; Dirk Lassner; Wolfgang Poller; Ursula Rauch; Carmen Scheibenbogen; Heinz-Peter Schultheiss; Carsten Skurk
High leptin and resistin expression in chronic heart failure: adverse outcome in patients with dilated and inflammatory cardiomyopathy.
European journal of heart failure 2012;14(11):1265-75.
2012: Madlen Löbel; Christian Meisel; Wolfgang Poller; Ursula Rauch; Sandra Bauer; Andreas Eisenreich; Robert Kudernatsch; Uwe Kühl; Heinz-Peter Schultheiss; Juliane Tank; Hans-Dieter Volk; Carmen Scheibenbogen
CCN1: a novel inflammation-regulated biphasic immune cell migration modulator.
Cellular and molecular life sciences : CMLS 2012;69(18):3101-13.
2012: Chin-An Yang; Gerald Grütz; Manuel Guerreiro; Doreen Haase; Lutz Hamann; Martin J Raftery; Günther Schönrich; Ralf R Schumann; Nadine Unterwalder; Hans-Dieter Volk; Carmen Scheibenbogen
Association of TLR3-hyporesponsiveness and functional TLR3 L412F polymorphism with recurrent herpes labialis.
Human immunology 2012;73(8):844-51.
2012: Wolfgang Poller; Madlen Rother; Carsten Skurk; Carmen Scheibenbogen
Endogenous migration modulators as parent compounds for the development of novel cardiovascular and anti-inflammatory drugs.
British journal of pharmacology 2012;165(7):2044-58.
2011: Sabrina Wilk; Nalân Utku; Hans D Volk; Sandra Bauer; Diana Elligsen-Merkel; Nicole Goerner; Manuel Guerreiro; Alexander Jenke; Robert Kudernatsch; Jordi Magrane; Wolfgang Poller; Madlen Rother; Carmen Scheibenbogen; Carsten Skurk
Adiponectin is a negative regulator of antigen-activated T cells.
European journal of immunology 2011;41(8):2323-32.
2011: Peter Bobbert; Carmen Scheibenbogen; Alexander Jenke; Gabriele Kania; Sabrina Wilk; Stefanie Krohn; Jenny Stehr; Uwe Kuehl; Ursula Rauch; Urs Eriksson; Heinz-Peter Schultheiss; Wolfgang Poller; Carsten Skurk
Adiponectin expression in patients with inflammatory cardiomyopathy indicates favourable outcome and inflammation control.
European heart journal 2011;32(9):1134-47.
2011: Sebastian Ochsenreither; Alberto Fusi; Antonia Busse; Sandra Bauer; Carmen Scheibenbogen; David Stather; Eckhard Thiel; Ulrich Keilholz; Anne Letsch
"Wilms Tumor Protein 1" (WT1) peptide vaccination-induced complete remission in a patient with acute myeloid leukemia is accompanied by the emergence of a predominant T-cell clone both in blood and bone marrow.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2011;34(1):85-91.
2010: Madlen Rother; Stefanie Krohn; Gabriela Kania; Davy Vanhoutte; Andreas Eisenreich; Xiaomin Wang; Dirk Westermann; Kostas Savvatis; Nadine Dannemann; Carsten Skurk; Denise Hilfiker-Kleiner; Toni Cathomen; Henry Fechner; Ursula Rauch; Heinz-Peter Schultheiss; Stephane Heymans; Urs Eriksson; Carmen Scheibenbogen; Wolfgang Poller
Matricellular signaling molecule CCN1 attenuates experimental autoimmune myocarditis by acting as a novel immune cell migration modulator.
Circulation 2010;122(25):2688-98.
2010: Manuel Guerreiro; Il-Kang Na; Anne Letsch; Doreen Haase; Sandra Bauer; Christian Meisel; Andy Roemhild; Petra Reinke; Hans-Dieter Volk; Carmen Scheibenbogen
Human peripheral blood and bone marrow Epstein-Barr virus-specific T-cell repertoire in latent infection reveals distinct memory T-cell subsets.
European journal of immunology 2010;40(6):1566-76.
2010: Sebastian Ochsenreither; Alberto Fusi; Antonia Busse; Anne Letsch; Doreen Haase; Eckhard Thiel; Carmen Scheibenbogen; Ulrich Keilholz
Long term presence of a single predominant tyrosinase-specific T-cell clone associated with disease control in a patient with metastatic melanoma.
International journal of cancer. Journal international du cancer 2010;126(10):2497-502.
2010: Oliver Hohn; Kristin Strohschein; Alexander U Brandt; Sandra Seeher; Sandra Klein; Reinhard Kurth; Friedemann Paul; Christian Meisel; Carmen Scheibenbogen; Norbert Bannert
No evidence for XMRV in German CFS and MS patients with fatigue despite the ability of the virus to infect human blood cells in vitro.
PloS one 2010;5(12):e15632.
2010: Antonia Busse; Anne Letsch; Carmen Scheibenbogen; Anika Nonnenmacher; Sebastian Ochsenreither; Eckhard Thiel; Ulrich Keilholz
Mutation or loss of Wilms' tumor gene 1 (WT1) are not major reasons for immune escape in patients with AML receiving WT1 peptide vaccination.
Journal of translational medicine 2010;8():5.
2009: Il-Kang Na; Anne Letsch; Manuel Guerreiro; Sandra Bauer; Ines Noack; Jens Geginat; Petra Reinke; Michael Loesch; Heino Kienapfel; Eckhard Thiel; Hans Dieter Volk; Carmen Scheibenbogen
Human bone marrow as a source to generate CMV-specific CD4+ T cells with multifunctional capacity.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2009;32(9):907-13.
2009: Conny Hoeflich; Nadine Unterwalder; Sabine Schuett; Kathrin Schmolke; Olaf Boenisch; Markus Hammer; Ramona Scheufele; Dagmar Michael; Hans-Dieter Volk; Carmen Scheibenbogen; Volker von Baehr; Christian Meisel
Clinical manifestation of mannose-binding lectin deficiency in adults independent of concomitant immunodeficiency.
Human immunology 2009;70(10):809-12.
2009: Ulrich Keilholz; Anne Letsch; Antonia Busse; Anne Marie Asemissen; Sandra Bauer; Igor Wolfgang Blau; Wolf-Karsten Hofmann; Lutz Uharek; Eckhard Thiel; Carmen Scheibenbogen
A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS.
Blood 2009;113(26):6541-8.
2009: Anne Marie Asemissen; Doreen Haase; Stefan Stevanovic; Sandra Bauer; Antonia Busse; Eckhard Thiel; Hans-Georg Rammensee; Ulrich Keilholz; Carmen Scheibenbogen
Identification of an immunogenic HLA-A*0201-binding T-cell epitope of the transcription factor PAX2.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2009;32(4):370-5.
2009: Kerstin Schmidt; Karl Seeger; Carmen Scheibenbogen; Roderich Bender; Majd Abdulla; Sina Süssmilch; Abdulgabar Salama; Anja Moldenhauer
Histone deacetylase inhibition improves differentiation of dendritic cells from leukemic blasts of patients with TEL/AML1-positive acute lymphoblastic leukemia.
Journal of leukocyte biology 2009;85(3):563-73.
2009: Georg Wieczorek; Anne Asemissen; Fabian Model; Ivana Turbachova; Stefan Floess; Volker Liebenberg; Udo Baron; Diana Stauch; Katja Kotsch; Johann Pratschke; Alf Hamann; Christoph Loddenkemper; Harald Stein; Hans Dieter Volk; Ulrich Hoffmüller; Andreas Grützkau; Alexander Mustea; Jochen Huehn; Carmen Scheibenbogen; Sven Olek
Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue.
Cancer research 2009;69(2):599-608.
2008: Il-Kang Na; Carmen Scheibenbogen; Christine Adam; Andrea Stroux; Pirus Ghadjar; Eckhard Thiel; Ulrich Keilholz; Sarah Ellen Coupland
Nuclear expression of CXCR4 in tumor cells of non-small cell lung cancer is correlated with lymph node metastasis.
Human pathology 2008;39(12):1751-5.
2008: Pirus Ghadjar; Christoph Loddenkemper; Sarah Ellen Coupland; Andrea Stroux; Michel Noutsias; Eckhard Thiel; Frank Christoph; Kurt Miller; Carmen Scheibenbogen; Ulrich Keilholz
Chemokine receptor CCR6 expression level and aggressiveness of prostate cancer.
Journal of cancer research and clinical oncology 2008;134(11):1181-9.
2008: Il-Kang Na; Antonia Busse; Carmen Scheibenbogen; Pirus Ghadjar; Sarah Ellen Coupland; Anne Letsch; Christoph Loddenkemper; Andrea Stroux; Sandra Bauer; Eckhard Thiel; Ulrich Keilholz
Identification of truncated chemokine receptor 7 in human colorectal cancer unable to localize to the cell surface and unreactive to external ligands.
International journal of cancer. Journal international du cancer 2008;123(7):1565-72.
2008: Philipp Kiewe; Veit Mansmann; Carmen Scheibenbogen; Heinz-Johannes Buhr; Eckhard Thiel; Dirk Nagorsen
HLA-A2 expression, stage, and survival in colorectal cancer.
International journal of colorectal disease 2008;23(8):767-72.
2008: Antonia Busse; Marianne Kraus; Il-Kang Na; Anika Rietz; Carmen Scheibenbogen; Christoph Driessen; Igor Wolfgang Blau; Eckhard Thiel; Ulrich Keilholz
Sensitivity of tumor cells to proteasome inhibitors is associated with expression levels and composition of proteasome subunits.
Cancer 2008;112(3):659-70.
2007: Anne Letsch; Maren Knoedler; Il-Kang Na; Florian Kern; Anne Marie Asemissen; Ulrich Keilholz; Michael Loesch; Eckhard Thiel; Hans-Dieter Volk; Carmen Scheibenbogen
CMV-specific central memory T cells reside in bone marrow.
European journal of immunology 2007;37(11):3063-8.
2007: Il-Kang Na; Ulrich Keilholz; Anne Letsch; Sandra Bauer; Anne Marie Asemissen; Dirk Nagorsen; Eckhard Thiel; Carmen Scheibenbogen
Addition of GM-CSF to a peptide/KLH vaccine results in increased frequencies of CXCR3-expressing KLH-specific T cells.
Cancer immunology, immunotherapy : CII 2007;56(3):391-6.
2007: Ronny Schuster; Nikolaos E Bechrakis; Andrea Stroux; Antonia Busse; Alexander Schmittel; Carmen Scheibenbogen; Eckhard Thiel; Michael H Foerster; Ulrich Keilholz
Circulating tumor cells as prognostic factor for distant metastases and survival in patients with primary uveal melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(4):1171-8.
2006: Anne Marie Asemissen; Ulrich Keilholz; Stefan Tenzer; Margret Müller; Steffen Walter; Stefan Stevanovic; Hansjörg Schild; Anne Letsch; Eckhard Thiel; Hans-Georg Rammensee; Carmen Scheibenbogen
Identification of a highly immunogenic HLA-A*01-binding T cell epitope of WT1.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(24):7476-82.
2006: Andreas Wadle; Gerhard Held; Frank Neumann; Sascha Kleber; Beate Wuellner; Anne Marie Asemissen; Boris Kubuschok; Carmen Scheibenbogen; Tanja Breinig; Andreas Meyerhans; Christoph Renner
Cross-presentation of HLA class I epitopes from influenza matrix protein produced in Saccharomyces cerevisiae.
Vaccine 2006;24(37-39):6272-81.
2006: Pirus Ghadjar; Sarah Ellen Coupland; Il-Kang Na; Michel Noutsias; Anne Letsch; Andrea Stroux; Sandra Bauer; Heinz J Buhr; Eckhard Thiel; Carmen Scheibenbogen; Ulrich Keilholz
Chemokine receptor CCR6 expression level and liver metastases in colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(12):1910-6.
2006: Robert Godal; Ulrich Keilholz; Lutz Uharek; Anne Letsch; Anne Marie Asemissen; Antonia Busse; Il-Kang Na; Eckhard Thiel; Carmen Scheibenbogen
Lymphomas are sensitive to perforin-dependent cytotoxic pathways despite expression of PI-9 and overexpression of bcl-2.
Blood 2006;107(8):3205-11.
2006: Ulrich Keilholz; Peter Martus; Carmen Scheibenbogen
Immune monitoring of T-cell responses in cancer vaccine development.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(7 Pt 2):2346s-2352s.
2006: Anne Letsch; Ulrich Keilholz; Florian Kern; Anne Marie Asemissen; Eckhard Thiel; Carmen Scheibenbogen
Specific central memory T cells in the bone marrow of patients immunized against tyrosinase peptides.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2006;29(2):201-7.
2006: Alexander Schmittel; Carmen Scheibenbogen; Anne Letsch; Anne Marie Asemissen; Eckhard Thiel; Ulrich Keilholz
Malignant melanoma--clinical development of peptide-based melanoma vaccines.
Frontiers of radiation therapy and oncology 2006;39():171-80.
2005: Ulrich Keilholz; Hans D Menssen; A Gaiger; A Menke; Y Oji; Y Oka; Carmen Scheibenbogen; H Stauss; Eckhard Thiel; H Sugiyama
Wilms' tumour gene 1 (WT1) in human neoplasia.
Leukemia 2005;19(8):1318-23.
2005: Kristoph Jahnke; Sarah E Coupland; Il-Kang Na; Christoph Loddenkemper; Ulrich Keilholz; Agnieszka Korfel; Harald Stein; Eckhard Thiel; Carmen Scheibenbogen
Expression of the chemokine receptors CXCR4, CXCR5, and CCR7 in primary central nervous system lymphoma.
Blood 2005;106(1):384-5.
2005: Anne Letsch; Ulrich Keilholz; Michael Fluck; Dirk Nagorsen; Anne Marie Asemissen; Alexander Schmittel; Eckhard Thiel; Carmen Scheibenbogen
Peptide vaccination after repeated resection of metastases can induce a prolonged relapse-free interval in melanoma patients.
International journal of cancer. Journal international du cancer 2005;114(6):936-41.
2005: Olaf Penack; Chiara Gentilini; Lars Fischer; Anne Marie Asemissen; Carmen Scheibenbogen; Eckhard Thiel; Lutz Uharek
CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targets.
Leukemia 2005;19(5):835-40.
2005: Michael T Lotze; Ena Wang; Francesco M Marincola; Nabil Hanna; Peter J Bugelski; Christine A Burns; George Coukos; Nitin Damle; Tony E Godfrey; W Martin Howell; Monica C Panelli; Michael A Perricone; Emanuel F Petricoin; Guido Sauter; Carmen Scheibenbogen; Steve Shivers; D Lansing Taylor; John N Weinstein; Theresa L Whiteside
Workshop on cancer biometrics: identifying biomarkers and surrogates of cancer in patients: a meeting held at the Masur Auditorium, National Institutes of Health.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2005;28(2):79-119.
2005: Anne Marie Asemissen; Carmen Scheibenbogen; Anne Letsch; Kristoffer Hellstrand; Fredrik B Thorén; Kurt Gehlsen; Alexander Schmittel; Eckhard Thiel; Ulrich Keilholz
Addition of histamine to interleukin 2 treatment augments type 1 T-cell responses in patients with melanoma in vivo: immunologic results from a randomized clinical trial of interleukin 2 with or without histamine (MP 104).
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(1):290-7.
2004: Alexander Schmittel; Nikolaos E Bechrakis; Peter Martus; Dominic Mutlu; Carmen Scheibenbogen; Norbert Bornfeld; Michael H Foerster; Eckhard Thiel; Ulrich Keilholz
Independent prognostic factors for distant metastases and survival in patients with primary uveal melanoma.
European journal of cancer (Oxford, England : 1990) 2004;40(16):2389-95.
2004: Dirk Nagorsen; Carmen Scheibenbogen; Eckhard Thiel; Ulrich Keilholz
Immunological monitoring of cancer vaccine therapy.
Expert opinion on biological therapy 2004;4(10):1677-84.
2004: Anne Letsch; Ulrich Keilholz; Dirk Schadendorf; Geraldine Assfalg; Anne Marie Asemissen; Eckhard Thiel; Carmen Scheibenbogen
Functional CCR9 expression is associated with small intestinal metastasis.
The Journal of investigative dermatology 2004;122(3):685-90.
2004: Ulrich Keilholz; Petra Goldin-Lang; Nikolaos E Bechrakis; Nicole Max; Anne Letsch; Alexander Schmittel; Carmen Scheibenbogen; Karin Heufelder; Alexander Eggermont; Eckhard Thiel
Quantitative detection of circulating tumor cells in cutaneous and ocular melanoma and quality assessment by real-time reverse transcriptase-polymerase chain reaction.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(5):1605-12.
2004: Volker Mailänder; Carmen Scheibenbogen; Eckhard Thiel; Anne Letsch; Igor Wolfgang Blau; Ulrich Keilholz
Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicity.
Leukemia 2004;18(1):165-6.
2003: Carmen Scheibenbogen; Anne Letsch; Alexander Schmittel; Anne Marie Asemissen; Eckhard Thiel; Ulrich Keilholz
Rational peptide-based tumour vaccine development and T cell monitoring.
Seminars in cancer biology 2003;13(6):423-9.
2003: Dirk Nagorsen; Carmen Scheibenbogen; Francesco M Marincola; Anne Letsch; Ulrich Keilholz
Natural T cell immunity against cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(12):4296-303.
2003: Licia Rivoltini; Chiara Castelli; Matteo Carrabba; Vincenzo Mazzaferro; Lorenzo Pilla; Veronica Huber; Jorgelina Coppa; Gianfrancesco Gallino; Carmen Scheibenbogen; Paola Squarcina; Agata Cova; Roberto Camerini; Jonathan J Lewis; Pramod K Srivastava; Giorgio Parmiani
Human tumor-derived heat shock protein 96 mediates in vitro activation and in vivo expansion of melanoma- and colon carcinoma-specific T cells.
Journal of immunology (Baltimore, Md. : 1950) 2003;171(7):3467-74.
2003: Anne Letsch; Carmen Scheibenbogen
Quantification and characterization of specific T-cells by antigen-specific cytokine production using ELISPOT assay or intracellular cytokine staining.
Methods (San Diego, Calif.) 2003;31(2):143-9.
2003: Anne Letsch; Ulrich Keilholz; Geraldine Assfalg; Volker Mailänder; Eckhard Thiel; Carmen Scheibenbogen
Bone marrow contains melanoma-reactive CD8+ effector T cells and, compared with peripheral blood, enriched numbers of melanoma-reactive CD8+ memory T cells.
Cancer research 2003;63(17):5582-6.
2003: Martina Willhauck; Carmen Scheibenbogen; Michael Pawlita; Thomas Möhler; Eckhard Thiel; Ulrich Keilholz
Restricted T-cell receptor repertoire in melanoma metastases regressing after cytokine therapy.
Cancer research 2003;63(13):3483-5.
2003: Dirk Nagorsen; Carmen Scheibenbogen; Gerhard Schaller; Binta Leigh; Alexander Schmittel; Anne Letsch; Eckhard Thiel; Ulrich Keilholz
Differences in T-cell immunity toward tumor-associated antigens in colorectal cancer and breast cancer patients.
International journal of cancer. Journal international du cancer 2003;105(2):221-5.
2003: Danila Valmori; Maha Ayyoub; Charles Hesdorffer; Ulrich Keilholz; Carmen Scheibenbogen
A monoclonal melanoma-specific T-cell population phenotypically indistinguishable from CD3+ LGL-leukemia.
Blood 2003;101(11):4643-4.
2003: Carmen Scheibenbogen; Dirk Schadendorf; Nikolaos E Bechrakis; Dirk Nagorsen; Udo Hofmann; Fotini Servetopoulou; Anne Letsch; Armin Philipp; Michael H Foerster; Alexander Schmittel; Eckhard Thiel; Ulrich Keilholz
Effects of granulocyte-macrophage colony-stimulating factor and foreign helper protein as immunologic adjuvants on the T-cell response to vaccination with tyrosinase peptides.
International journal of cancer. Journal international du cancer 2003;104(2):188-94.
2003: Alexander Schmittel; Thomas M Proebstle; R Engenhart-Cabillic; Carmen Scheibenbogen; A M Geueke; Eckhard Thiel; Ulrich Keilholz
Brain metastases following interleukin-2 plus interferon-alpha-2a therapy: a follow-up study in 94 stage IV melanoma patients.
European journal of cancer (Oxford, England : 1990) 2003;39(4):476-80.
2002: Carmen Scheibenbogen; Anne Letsch; Eckhard Thiel; Alexander Schmittel; Volker Mailaender; Steffi Baerwolf; Dirk Nagorsen; Ulrich Keilholz
CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemia.
Blood 2002;100(6):2132-7.
2002: Carmen Scheibenbogen; Dirk Nagorsen; Barbara Seliger; Alexander Schmittel; Anne Letsch; Sandra Bauer; Nicole Max; Michaela Bock; Derek Atkins; Eckhard Thiel; Ulrich Keilholz
Long-term freedom from recurrence in 2 stage IV melanoma patients following vaccination with tyrosinase peptides.
International journal of cancer. Journal international du cancer 2002;99(3):403-8.
2002: Nikolaos E Bechrakis; Carmen Scheibenbogen; Alexander Schmittel; Fotini Servetopoulou; Michael H Foerster; Ulrich Keilholz
[Choroid melanoma. Adjuvant therapy in high risk patients and new therapy approaches in the metastatic stage].
Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2002;99(5):333-7.
2002: Carmen Scheibenbogen; Yuansheng Sun; Ulrich Keilholz; Mingxia Song; Stefan Stevanovic; Anne Marie Asemissen; Dirk Nagorsen; Eckhard Thiel; Hans-Georg Rammensee; Dirk Schadendorf
Identification of known and novel immunogenic T-cell epitopes from tumor antigens recognized by peripheral blood T cells from patients responding to IL-2-based treatment.
International journal of cancer. Journal international du cancer 2002;98(3):409-14.
2002: Danila Valmori; Carmen Scheibenbogen; Valérie Dutoit; Dirk Nagorsen; Anne Marie Asemissen; Verena Rubio-Godoy; Donata Rimoldi; Philippe Guillaume; Pedro Romero; Dirk Schadendorf; Martin Lipp; Pierre-Yves Dietrich; Eckhard Thiel; Jean-Charles Cerottini; Danielle Liénard; Ulrich Keilholz
Circulating Tumor-reactive CD8(+) T cells in melanoma patients contain a CD45RA(+)CCR7(-) effector subset exerting ex vivo tumor-specific cytolytic activity.
Cancer research 2002;62(6):1743-50.
2002: Ulrich Keilholz; Jeffrey Weber; James H Finke; Dmitry I Gabrilovich; W Martin Kast; Mary L Disis; John M Kirkwood; Carmen Scheibenbogen; Jeff Schlom; Vernon C Maino; H Kim Lyerly; Peter P Lee; Walter Storkus; Franceso Marincola; Alexandra Worobec; Michael B Atkins
Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological Therapy.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2002;25(2):97-138.
2001: Anne Marie Asemissen; Dirk Nagorsen; Ulrich Keilholz; Anne Letsch; Alexander Schmittel; Eckhard Thiel; Carmen Scheibenbogen
Flow cytometric determination of intracellular or secreted IFNgamma for the quantification of antigen reactive T cells.
Journal of immunological methods 2001;251(1-2):101-8.
2001: Alexander Schmittel; Ulrich Keilholz; S Bauer; U Kuhne; S Stevanovic; Eckhard Thiel; Carmen Scheibenbogen
Application of the IFN-gamma ELISPOT assay to quantify T cell responses against proteins.
Journal of immunological methods 2001;247(1-2):17-24.
2000: Carmen Scheibenbogen; P Romero; L Rivoltini; W Herr; Alexander Schmittel; J C Cerottini; T Woelfel; A M Eggermont; Ulrich Keilholz
Quantitation of antigen-reactive T cells in peripheral blood by IFNgamma-ELISPOT assay and chromium-release assay: a four-centre comparative trial.
Journal of immunological methods 2000;244(1-2):81-9.
2000: Dirk Nagorsen; Ulrich Keilholz; L Rivoltini; Alexander Schmittel; Anne Letsch; Anne Marie Asemissen; G Berger; H J Buhr; Eckhard Thiel; Carmen Scheibenbogen
Natural T-cell response against MHC class I epitopes of epithelial cell adhesion molecule, her-2/neu, and carcinoembryonic antigen in patients with colorectal cancer.
Cancer research 2000;60(17):4850-4.
2000: Anne Letsch; Ulrich Keilholz; Dirk Schadendorf; Dirk Nagorsen; Alexander Schmittel; Eckhard Thiel; Carmen Scheibenbogen
High frequencies of circulating melanoma-reactive CD8+ T cells in patients with advanced melanoma.
International journal of cancer. Journal international du cancer 2000;87(5):659-64.
2000: Alexander Schmittel; Ulrich Keilholz; Eckhard Thiel; Carmen Scheibenbogen
Quantification of tumor-specific T lymphocytes with the ELISPOT assay.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2000;23(3):289-95.
2000: Carmen Scheibenbogen; Alexander Schmittel; Ulrich Keilholz; T Allgäuer; U Hofmann; Regina Max; Eckhard Thiel; Dirk Schadendorf
Phase 2 trial of vaccination with tyrosinase peptides and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2000;23(2):275-81.
1999: Alexander Schmittel; Ulrich Keilholz; Regina Max; Eckhard Thiel; Carmen Scheibenbogen
Induction of tyrosinase-reactive T cells by treatment with dacarbazine, cisplatin, interferon-alpha +/- interleukin-2 in patients with metastatic melanoma.
International journal of cancer. Journal international du cancer 1999;80(1):39-43.
1998: Thomas M Proebstle; T Fuchs; Carmen Scheibenbogen; W Sterry; U Keilholz
Long-term outcome of treatment with dacarbazine, cisplatin, interferon-alpha and intravenous high dose interleukin-2 in poor risk melanoma patients.
Melanoma research 1998;8(6):557-63.
1998: U Keilholz; C Conradt; Sewa S Legha; David Khayat; Carmen Scheibenbogen; N Thatcher; S H Goey; M Gore; T Dorval; B Hancock; C J Punt; R Dummer; M F Avril; E B Bröcker; A Benhammouda; A M Eggermont; Maria Pritsch
Results of interleukin-2-based treatment in advanced melanoma: a case record-based analysis of 631 patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(9):2921-9.
1997: Alexander Schmittel; Ulrich Keilholz; Carmen Scheibenbogen
Evaluation of the interferon-gamma ELISPOT-assay for quantification of peptide specific T lymphocytes from peripheral blood.
Journal of immunological methods 1997;210(2):167-74.
1997: Ulrich Keilholz; Gerrit Stoter; C J Punt; Carmen Scheibenbogen; F Lejeune; A M Eggermont
Recombinant interleukin-2-based treatments for advanced melanoma: the experience of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group.
The cancer journal from Scientific American 1997;3 Suppl 1():S22-8.
1997: Ulrich Keilholz; Martina Willhauck; Carmen Scheibenbogen; Teun J de Vries; S Burchill
Polymerase chain reaction detection of circulating tumour cells. EORTC Melanoma Cooperative Group, Immunotherapy Subgroup.
Melanoma research 1997;7 Suppl 2():S133-41.
1997: Ulrich Keilholz; S H Goey; C J Punt; Thomas M Proebstle; R Salzmann; Carmen Scheibenbogen; Dirk Schadendorf; D Liénard; A Enk; R Dummer; B Hantich; A M Geueke; A M Eggermont
Interferon alfa-2a and interleukin-2 with or without cisplatin in metastatic melanoma: a randomized trial of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(7):2579-88.
1997: Carmen Scheibenbogen; KH Lee; S Stevanovic; Mathias Witzens; Martina Willhauck; V Waldmann; Helmut Naeher; Hans-Georg Rammensee; Ulrich Keilholz
Analysis of the T cell response to tumor and viral peptide antigens by an IFNgamma-ELISPOT assay.
International journal of cancer. Journal international du cancer 1997;71(6):932-6.
1997: Ulrich Keilholz; Regina Max; Carmen Scheibenbogen; Christian Wüster; M Körbling; Rainer Haas
Endocrine function and bone metabolism 5 years after autologous bone marrow/blood-derived progenitor cell transplantation.
Cancer 1997;79(8):1617-22.
1997: Mathias Witzens; Thomas Möhler; Martina Willhauck; Carmen Scheibenbogen; KH Lee; Ulrich Keilholz
Detection of clonally rearranged T-cell-receptor gamma chain genes from T-cell malignancies and acute inflammatory rheumatic disease using PCR amplification, PAGE, and automated analysis.
Annals of hematology 1997;74(3):123-30.
1997: Carmen Scheibenbogen; KH Lee; S Mayer; S Stevanovic; U Moebius; W Herr; Hans-Georg Rammensee; Ulrich Keilholz
A sensitive ELISPOT assay for detection of CD8+ T lymphocytes specific for HLA class I-binding peptide epitopes derived from influenza proteins in the blood of healthy donors and melanoma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(2):221-6.
1996: E Stoelben; M Nagel; Detlef Ockert; M Quintel; Carmen Scheibenbogen; B Klein; Hans-Detlev Saeger
[Clinical significance of cytokines Il-6, Il-8 and C-reactive protein in serum of patients with acute pancreatitis].
Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen 1996;67(12):1231-6.
1996: S Mayer; Carmen Scheibenbogen; K H Lee; W Keilholz; Stefan Stevanovic; Hans-Georg Rammensee; Ulrich Keilholz
A sensitive proliferation assay to determine the specific T cell response against HLA-A2.1-binding peptides.
Journal of immunological methods 1996;197(1-2):131-7.
1996: Carmen Scheibenbogen; Imke Weyers; D Ruiter; Martina Willhauck; A Bittinger; Ulrich Keilholz
Expression of gp100 in melanoma metastases resected before or after treatment with IFN alpha and IL-2.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1996;19(5):375-80.
1996: Thomas M Proebstle; Carmen Scheibenbogen; W Sterry; Ulrich Keilholz
A phase II study of dacarbazine, cisplatin, interferon-alpha and high-dose interleukin-2 in 'poor-risk' metastatic melanoma.
European journal of cancer (Oxford, England : 1990) 1996;32A(9):1530-3.
1996: T Möhler; Carmen Scheibenbogen; J Häfele; Martina Willhauck; Ulrich Keilholz
Regulation of interleukin-8 mRNA expression and protein secretion in a melanoma cell line by tumour necrosis factor-alpha and interferon-gamma.
Melanoma research 1996;6(4):307-11.
1996: Martina Willhauck; T Möhler; Carmen Scheibenbogen; M Pawlita; P Brossart; J W Schmier; Ulrich Keilholz
T-cell receptor beta variable region diversity in melanoma metastases after interleukin 2-based immunotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(4):767-72.
1996: Ulrich Keilholz; Carmen Scheibenbogen; M Sommer; M Pritsch; A M Geuke
Prognostic factors for response and survival in patients with metastatic melanoma receiving immunotherapy.
Melanoma research 1996;6(2):173-8.
1995: Alexander Schmittel; Carmen Scheibenbogen; Ulrich Keilholz
Lipopolysaccharide effectively up-regulates B7-1 (CD80) expression and costimulatory function of human monocytes.
Scandinavian journal of immunology 1995;42(6):701-4.
1995: P Brossart; J W Schmier; S Krüger; Martina Willhauck; Carmen Scheibenbogen; T Möhler; Ulrich Keilholz
A polymerase chain reaction-based semiquantitative assessment of malignant melanoma cells in peripheral blood.
Cancer research 1995;55(18):4065-8.
1995: Ulrich Keilholz; Carmen Scheibenbogen; T Möhler; P Brossart; D Maclachlan; A M Geueke; A Jochim; W Hunstein
Addition of dacarbazine or cisplatin to interferon-alpha/interleukin-2 in metastatic melanoma: toxicity and immunological effects.
Melanoma research 1995;5(4):283-7.
1995: Carmen Scheibenbogen; T Möhler; J Haefele; W Hunstein; Ulrich Keilholz
Serum interleukin-8 (IL-8) is elevated in patients with metastatic melanoma and correlates with tumour load.
Melanoma research 1995;5(3):179-81.
1995: T Möhler; Martina Willhauck; Carmen Scheibenbogen; M Pawlita; H Bludau; P Brossart; W Hunstein; Ulrich Keilholz
Restriction of T cell receptor V beta repertoire in melanoma metastasis responding to immunotherapy.
Melanoma research 1995;5(2):129-32.
1995: Ulrich Keilholz; Carmen Scheibenbogen; P Brossart; T Möhler; W Tilgen; W Hunstein
Interleukin-2-based immunotherapy and chemoimmunotherapy in metastatic melanoma.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1995;139():383-90.
1994: Carmen Scheibenbogen; Ulrich Keilholz; Joannis Mytilineos; S Suciu; M Manasterski; W Hunstein
HLA class I alleles and responsiveness of melanoma to immunotherapy with interferon-alpha (IFN-alpha) and interleukin-2 (IL-2).
Melanoma research 1994;4(3):191-4.
1994: Regine Landmann; U Keilholz; Carmen Scheibenbogen; M Brockhaus; H Gallati; H Denz; M Bargetzi; C Ludwig
Relationship between soluble tumor necrosis factor (TNF) receptors and TNF alpha during immunotherapy with interleukin-2 and/or interferon alpha.
Cancer immunology, immunotherapy : CII 1994;38(2):113-8.
1994: Ulrich Keilholz; Carmen Scheibenbogen; M Brado; P Georgi; D Maclachlan; B Brado; W Hunstein
Regional adoptive immunotherapy with interleukin-2 and lymphokine-activated killer (LAK) cells for liver metastases.
European journal of cancer (Oxford, England : 1990) 1994;30A(1):103-5.
1994: P Brossart; Ulrich Keilholz; Carmen Scheibenbogen; T Möhler; Martina Willhauck; W Hunstein
Detection of residual tumor cells in patients with malignant melanoma responding to immunotherapy.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1994;15(1):38-41.
1994: Ulrich Keilholz; Carmen Scheibenbogen; E Stoelben; Hans-Detlev Saeger; W Hunstein
Immunotherapy of metastatic melanoma with interferon-alpha and interleukin-2: pattern of progression in responders and patients with stable disease with or without resection of residual lesions.
European journal of cancer (Oxford, England : 1990) 1994;30A(7):955-8.
1994: Carmen Scheibenbogen; W Hunstein; Ulrich Keilholz
Vitiligo-like lesions following immunotherapy with IFN alpha and IL-2 in melanoma patients.
European journal of cancer (Oxford, England : 1990) 1994;30A(8):1209-11.
1993: P Brossart; Ulrich Keilholz; Martina Willhauck; Carmen Scheibenbogen; T Möhler; W Hunstein
Hematogenous spread of malignant melanoma cells in different stages of disease.
The Journal of investigative dermatology 1993;101(6):887-9.
1993: Ulrich Keilholz; Carmen Scheibenbogen; Wolfgang Tilgen; L Bergmann; Eckhart Weidmann; E Seither; M Richter; B Brado; Paris S Mitrou; W Hunstein
Interferon-alpha and interleukin-2 in the treatment of metastatic melanoma. Comparison of two phase II trials.
Cancer 1993;72(2):607-14.
1993: Carmen Scheibenbogen; Ulrich Keilholz; Stefan C Meuer; Thomas J Dengler; Wolfgang Tilgen; W Hunstein
Differential expression and release of LFA-3 and ICAM-1 in human melanoma cell lines.
International journal of cancer. Journal international du cancer 1993;54(3):494-8.
1993: Carmen Scheibenbogen; Ulrich Keilholz; A Pezzutto; W Hunstein
Rheumatic disease following immunotherapy.
Annals of the rheumatic diseases 1993;52(2):165.
1992: Carmen Scheibenbogen; Ulrich Keilholz; M Richter; R Andreesen; W Hunstein
The interleukin-2 receptor in human monocytes and macrophages: regulation of expression and release of the alpha and beta chains (p55 and p75).
Research in immunology 1992;143(1):33-7.